Quantification of serotonin 5-HT1A receptors in monkey brain with [11C](R)-(-)-RWAY

Synapse

Volumn 60, Issue 7, 2006, Pages 510-520

  Yasuno, Fumihiko ^a   Zoghbi, Sami S ^a   McCarron, Julie A ^a   Hong, Jinsoo ^a   Ichise, Masanori ^a   Brown, Amira K ^a   Gladding, Robert L ^a   Bacher, John D ^b   Peke, Victor W ^a   Innis, Robert B ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

11C (R) ( ) RWAY; Kinetic analysis; P glycoprotein; PET; Serotonin 5 HT1A

Indexed keywords

2,3,4,5,6,7 HEXAHYDRO 1 [4 [1 [4 (2 METHOXYPHENYL)PIPERAZINYL]]] 2 PHENYLBUTYRYL 1H AZEPINE C 11; ARYLBUTYRIC ACID DERIVATIVE; CARBON 11; GLYCOPROTEIN P; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RADIOLIGAND; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; TARIQUIDAR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG UPTAKE; ISOTOPE LABELING; LIGAND BINDING; MALE; MATHEMATICAL MODEL; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; RHESUS MONKEY;

ANIMALS; AZEPINES; BINDING, COMPETITIVE; BLOOD-BRAIN BARRIER; BRAIN; BRAIN MAPPING; CARBON RADIOISOTOPES; MACACA MULATTA; MALE; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; P-GLYCOPROTEIN; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; QUINOLINES; RADIOLIGAND ASSAY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 33749576767     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20327     Document Type: Article

References (35)

1. Akaike H. 1974. A new look at the statistical model identification. IEEE Trans Automat Control AC19:716-723.
2. Aloyo VJ, Harvey JA, Kirifides AL. 1993. Chronic cocaine increases win 35428 binding in rabbit caudate. Soc Neurosci Abstr 19:1843.
3. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM. 2003. P-glycoprotein: From genomics to mechanism. Oncogene 22:7468-7485
4. Bevington PR, Robinson DK. 2003. Data reduction and error analysis for the physical sciences. New York: McGraw-Hill.
5. Burger C, Mikolajczyk K, Grodzki M, Rudnicki P, Szabatin M, Buck A. 1998. JAVA tools quantitative post-processing of brain PET data. J Nucl Med 39(Suppl):277.
6. Carson R. 1986. Parameter estimation in positron emission tomography. In: Phelps M, Mazziotta J, Schelbert H, editors. Positron emission tomography and autoradiography: Principles and applications for the brain and heart. New York: Raven Press. p 347-390.
7. Cunningham V, Lammertsma A. 1995. Radioligand studies in brain: Kinetic analysis of PET data. Med Chem Res 5:79-96.
8. Elsinga PH, Hendrikse NH, Bart J, Vaalburg W, van Waarde A. 2004. PET Studies on P-glycoprotein function in the blood-brain barrier: How it affects uptake and binding of drugs within the CNS. Curr Pharm Des 10:1493-1503.
9. Farde L, Ito H, Swahn C, Pike V, Halldin C. 1998. Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. J Nucl Med 39:1965-1971.
10. Gandelman MS, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Innis RB. 1994. Evaluation of ultrafiltration for the free fraction determination of single photon emission computed tomography (SPECT) tracers: β-CIT, IBF, and iomazenil. J Pharm Sci 83:1014-1019.
11. 11C]WAY-100635 for PET. Neuroimage 8:426-440.
12. 11C]WAY-100635. Brain Res 745:96-108.
13. Hawkins RA, Phelps ME, Huang S-C. 1986. Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: Studies in human brain tumors with PET. J Cereb Blood Flow Metab 6:170-183.
14. Ichise M, Toyama H, Innis RB, Carson RE. 2002. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb Blood Flow Metab 22:1271-1281.
15. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23:1096-1112.
16. Lammertsma AA, Hume SP. 1996. Simplified reference tissue model for PET receptor studies. Neuroimage 4:153-158.
17. Lammerstma AA, Bench CJ, Hume SP, Osman S, Gunn K, Brooks DJ, Frackowiak RS. 1996. Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab 16:42-52.
18. 11C-methyl]-(-)cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10:740-747.
19. 11C-carboxylation of an immobilized Grignard reagent. J Labelled Compd Radiopharm 38:941-953.
20. 1A receptors based on 2,3,4,5,6,7- hexahydro-1{4-[1[4-7(2-methoxyphenyl)-piperazinyl]]-2-phenylbutyryl}-1H-azepine (RWAY). Neuroimage 22(Suppl 2):T34-T35.
21. Mistry P, Stewart AJ, Dangerfield W, Okiji S, Liddle C, Bootle D, Plumb JA, Templeton D, Charlton P. 2001. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. Cancer Res 61:749-758.
22. 11C]WAY-100635 binding: Considerations on the cerebellum. Nucl Med Biol 27:483-486.
23. 11C]WAY-100635: Explanation of high signal contrast in PET and aid to biomathematical modeling. Nucl Med Biol 25:215-223.
24. 18F]MPPF in rats. Eur J Pharmacol 407:273-280.
25. Paxinos G, Huang X-F, Toga A. 2000. The rhesus monkey brain in stereotaxic coordinates. San Diego: Academic Press.
26. 11C]WAY-100635. Med Chem Res 5:208.
27. 11C]WAY-100635. Eur J Pharmacol 301:R5-R7.
28. Roe M, Folkes A, Ashworth P, Brumwell J, Chima L, Hunjan S, Pretswell I, Dangerfield W, Ryder H, Charlton P. 1999. Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives. Bioorg Med Chem Lett 9:595-600.
29. 11C]RWAY by LC-MS. J Labelled Compd Radiopharm 48(Suppl 1):278.
30. 11C]WAY-100635 binding parameters with reference tissue models: Effect of violations of model assumptions. Nucl Med Biol 27:487-492.
31. Susula GM, Atkinson JR. 2000. Effects of liver disease on pharmacokinetics. In: Atkinson JR, Daniels CE, Dedrick RL, Grudzinskas CV, Markey SP, editors. Principles of clinical pharmacology. San Diego: Academic Press. p 63-74.
32. 11C]carfentanil in the baboon. J Nucl Med 44(Suppl):35.
33. Vaalburg W, Hendrikse N, Elsinga P, Bart J, van Waarde A. 2005. P-glycoprotein activity and biological response. Toxicol Appl Pharmacol 207:257-260.
34. 1A receptor binding in amygdala of schizophrenia. Biol Psychiatry 55:439-444.
35. 18F]FECNT: A polar radiolabeled metabolite confounds brain radioligand measurements. J Nucl Med 47:520-527.